Aya El Helali/LinkedIn
Jul 21, 2025, 18:29
Aya El Helali: Reporting Clinical Trials in the Era of Precision Oncology at ESMO TAT Asia 2025
Aya El Helali, Vice President at Hong Kong Neuro-Oncology Society and Chair of The University of Hong Kong and Hong Kong Sanatorium Hospital Molecular Tumor Board, shared a post on LinkedIn:
“Thank you for joining us this morning at our session on Reporting Clinical Trials in the era of Precision Oncology at ESMO TAT Asia 2025 (ESMO – European Society for Medical Oncology) with a stellar panel of experts Annie Wong, Darren Wan-Teck Lim, and Herbert Loong.
Stay tuned for more updates and highlights from ESMO TAT Asia 2025!”
More posts featuring Aya El Helali.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 14, 2025, 22:19
Aug 14, 2025, 20:54
Aug 14, 2025, 19:43
Aug 14, 2025, 19:33
Aug 14, 2025, 19:24
Aug 14, 2025, 19:11
Aug 14, 2025, 19:00
Aug 14, 2025, 18:48